Detailed information for compound 1740005

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 490.591 | Formula: C29H34N2O5
  • H donors: 3 H acceptors: 3 LogP: 5.7 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=CCc1cc(ccc1O)C(=O)Nc1cc2ccc(c(c2oc1=O)C)OCCC1CCCCN1)C
  • InChi: 1S/C29H34N2O5/c1-18(2)7-8-20-16-22(9-11-25(20)32)28(33)31-24-17-21-10-12-26(19(3)27(21)36-29(24)34)35-15-13-23-6-4-5-14-30-23/h7,9-12,16-17,23,30,32H,4-6,8,13-15H2,1-3H3,(H,31,33)
  • InChiKey: PIYFCRYDLSTURB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) CMGC/CDK/CDK8 protein kinase 0.0405 0.6362 0.6361
Echinococcus granulosus cyclin dependent kinase 19 0.0405 0.6362 1
Onchocerca volvulus 0.0007 0.0003 0.5
Onchocerca volvulus 0.0007 0.0003 0.5
Echinococcus multilocularis cyclin 0.0314 0.4907 0.7713
Echinococcus granulosus oligomeric golgi complex subunit 3 0.0314 0.4907 0.7713
Onchocerca volvulus 0.0007 0.0003 0.5
Brugia malayi Cyclin, N-terminal domain containing protein 0.0314 0.4907 0.4906
Loa Loa (eye worm) cyclin C 0.0632 1 1
Entamoeba histolytica SH2-protein kinase domain containing protein 0.0007 0.0003 0.0005
Onchocerca volvulus 0.0007 0.0003 0.5
Brugia malayi Protein kinase domain containing protein 0.0405 0.6362 0.6361
Schistosoma mansoni serine/threonine protein kinase 0.0405 0.6362 0.6361
Echinococcus multilocularis cyclin dependent kinase 19 0.0405 0.6362 1
Schistosoma mansoni g1/s-specific cyclin C 0.0632 1 1
Onchocerca volvulus 0.0007 0.0003 0.5
Loa Loa (eye worm) gastrulation defective protein 1 0.0403 0.6339 0.6338
Echinococcus granulosus cyclin 0.0314 0.4907 0.7713
Entamoeba histolytica cyclin C, putative 0.0318 0.498 1
Loa Loa (eye worm) cyclin domain-containing protein 0.0314 0.4907 0.4906
Echinococcus multilocularis oligomeric golgi complex subunit 3 0.0314 0.4907 0.7713
Echinococcus granulosus tyrosine protein kinase Lyn 0.0009 0.0025 0.0036
Onchocerca volvulus 0.0007 0.0003 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.71 uM Antiproliferative activity against human MCF7 cells ChEMBL. 23234644

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 23234644

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.